Advertising Survey

We would like your input on how advertising is currently used in the site.

Please take this short survey to help us out.

Hide this message

Undecenoate preparations

  • These preparations should not be used on areas that are bleeding, or come into contact with the eyes, ears, or mucous membranes (eg mouth, vagina, inside of nose etc.)

About undecenoate preparations

Type of medicineAntifungals
Used forThe treatment of tinea (fungal) infections of the skin. Tinea infections are also sometimes known as ringworm
Also calledMycota®
Available asCream, powder and spray

Undecenoate preparations work by killing the fungus that causes the tinea infection.

The word tinea is sometimes followed by the Latin term for the affected part of the body, for example, tinea pedis (feet), tinea cruris (groin), tinea corporis (body) and tinea manuum (hands).

The appearance and symptoms of tinea vary according to the site. The most common type is tinea pedis, also called athlete's foot, which causes cracking and itching between the toes. Tinea corporis is characterised by itchy patches on the body that are usually circular with a prominent edge. Tinea cruris (also commonly called jock itch) produces a reddened, itchy area spreading from the genitals outwards over the inside of the thigh. This form of tinea is more common in males.

Before using undecenoate preparations

Before using undecenoate preparations make sure your doctor or pharmacist knows:

  • If you are pregnant, trying for a baby or breast-feeding.
  • If you have ever had an allergic reaction to this or any other medicine.
  • If you are using any other preparations, including those available to buy without a prescription, herbal or complementary medicines.

How to use undecenoate preparations

  • Use this preparation exactly as directed by your doctor.
  • Always read the manufacturer's information leaflet, if possible before beginning treatment.
  • Undecenoate preparations for the treatment of athlete's foot are usually applied twice a day and continued for seven days after symptoms have disappeared. Undecenoates can also be applied once a day to prevent athlete's foot.

Getting the most from your treatment

  • Do not allow undecenoate preparations to come into contact with the eyes, ears, or mucous membranes (for example, the mouth, vagina, or inside of the nose).
  • Continue to use the treatment for 1 - 2 weeks after all signs of the infection have disappeared. This will help stop the infection from returning.
  • Before using any 'over-the-counter' medicines, check with your pharmacist which medicines are safe for you to use alongside this preparation.

Can undecenoate preparations cause problems

Along with their useful effects all medicines can cause unwanted side effects, which usually improve as your body adjusts to the new medicine.

Common side-effects What can I do if I experience this
Skin irritation such as redness, itching, or stingingThis should soon disappear. If it doesn't or if it becomes severe, stop using the preparation and ask your doctor or pharmacist for advice

How to store undecenoate preparations

  • Keep all medicines out of the reach of children.
  • Store in a cool, dry place, away from direct heat and light.

Important information about all medicines


  • If you suspect that someone has taken this medicine, contact the accident and emergency department of your local hospital at once. If you are asked to go to the hospital, take the container with you if possible, even if it is empty.
  • If you are having any treatment like an operation or dental treatment tell the person carrying out the treatment which medicines you are taking.
  • This medicine is for you. Never give it to other people even if their condition appears to be the same as yours.
  • Never keep out of date or unwanted medicines. Take them to your local pharmacy which will dispose of them for you.
  • If you have any questions about this medicine ask your pharmacist.

References

  • British National Formulary; 54th Edition (September 2007) British Medical Association and Royal Pharmaceutical Society of Great Britain, London
Comprehensive patient resources are available at www.patient.co.uk
© EMIS 2008DocID:
3742
DocRef:
dils3736
Last Reviewed:
20 Oct 2008
Version:
23
Provide feedback